The medicines decisions made at the NENC Clinical Effectiveness and Governance (CEG) Subcommittee July 2026 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/
This includes the recommendations made by NTAG at its July 2026 meeting and NICE Technology appraisals from the 1st April 2026 to 31st May 2026.
The following new guidelines were approved and can be found at:
- Nil
The following reviewed/updated guidelines were approved and can be found at:
- NENC Agomelatine – Prescribing and Monitoring in Adults – Information for Primary Care – due review April 2026 – no significant updates https://ntag.nhs.uk/wp-content/uploads/2026/07/NENC-Agomelatine-Prescribing-and-Monitoring-in-Adults-Information-for-Primary-Care-v2-approved-July-2026.pdf
- NENC Position statement on the prescribing of branded generic medication – due review Feb 2026 – reformatted and no significant changes to content https://ntag.nhs.uk/wp-content/uploads/2026/07/NENC-Position-statement-on-Branded-Generics-v3-approved-July-2026.pdf
- NENC Regional Adult Headache Guideline – no significant updates. Updates as per update as per July 2026 CEG decision summary https://ntag.nhs.uk/wp-content/uploads/2026/07/North-East-and-North-Cumbria-Adult-Headache-Guideline-June-2026.pdf
- NENC Adult asthma and age 12 – 17 years guidelines – technical update Change of image and wording of ” Aerochamber Plus” to “Aerochamber Plus Flow-Vu” (the flow vu device creates a whistle if the patient inhales too fast. https://ntag.nhs.uk/wp-content/uploads/2026/07/NENC-Adult-asthma-guidelines-v2.2-approved-July-2026.pdf and https://ntag.nhs.uk/wp-content/uploads/2026/07/NENC-Asthma-Prescribing-Guidelines-for-Children-and-Young-People-12-to-17-years-approved-July-2026-v1.1.pdf
- NENC Guidelines for the recognition and management of non-IgE cow’s milk allergy (CMA) in infants – technical update – Minor changes are on pages 8 & 9, where the brands available have been updated. https://ntag.nhs.uk/wp-content/uploads/2026/07/NENC-Guidelines-for-the-recognition-and-management-of-non-IgE-cows-milk-allergy-CMA-in-infants-v1.3-July-2026.pdf
The following reviewed and updated shared care guidelines were approved and can be found at:
- NENC Shared Care Protocol – Sativex for the treatment of spasticity in multiple sclerosis – technical update to recommend that a lower daily Sativex dose may be required in patients with moderate or severe renal impairment https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Methotrexate (oral and subcutaneous) for patients in adult services (excluding cancer care) – technical update as per change table on front page and July 2026 CEG decision summary. https://ntag.nhs.uk/shared-care-guidelines/
The following were also approved:
- NENC ICB Position Statement: Primary Care Prescribing of Vitamin B12 https://ntag.nhs.uk/wp-content/uploads/2026/07/NENC-ICB-Position-Statement-Primary-Care-Prescribing-of-Vitamin-B12-approved-July-2026.pdf
- NENC ICB Position Statement on Promethazine in Primary Care https://ntag.nhs.uk/wp-content/uploads/2026/07/NENC-ICB-Position-Statement-on-Promethazine-in-Primary-Care-approved-July-2026.pdf
The following shared care guidelines have had their review date extended:
- NENC Shared Care Protocol – Azathioprine and mercaptopurine within adult services (non-transplant indications) – extended to March 2027 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Ciclosporin (oral) for patients within adult services (non-transplant indications) – extended to March 2027 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Hydroxychloroquine for patients within adult services – extended to March 2027 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Leflunomide for patients within adult services – extended to March 2027 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Methotrexate (oral and subcutaneous) for patients in adult services (excluding cancer care) – extended to March 2027 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Mycophenolate mofetil and mycophenolic acid in adults (non-transplant indications) – extended to March 2027 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Sulfasalazine for patients within adult services- extended to March 2027 https://ntag.nhs.uk/shared-care-guidelines/